BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21893069)

  • 1. Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.
    Unno M; Shinohara M; Takayama K; Tanaka H; Teruya K; Doh-ura K; Sakai R; Sasaki M; Ikeda-Saito M
    J Mol Biol; 2011 Oct; 413(3):667-83. PubMed ID: 21893069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.
    Lash-Van Wyhe LL; Postila PA; Tsubone K; Sasaki M; Pentikäinen OT; Sakai R; Swanson GT
    Neuropharmacology; 2010 Mar; 58(3):640-9. PubMed ID: 19962997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine.
    Frydenvang K; Lash LL; Naur P; Postila PA; Pickering DS; Smith CM; Gajhede M; Sasaki M; Sakai R; Pentikaïnen OT; Swanson GT; Kastrup JS
    J Biol Chem; 2009 May; 284(21):14219-29. PubMed ID: 19297335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of binding site residues responsible for the subunit selectivity of novel marine-derived compounds on kainate receptors.
    Sanders JM; Pentikäinen OT; Settimo L; Pentikäinen U; Shoji M; Sasaki M; Sakai R; Johnson MS; Swanson GT
    Mol Pharmacol; 2006 Jun; 69(6):1849-60. PubMed ID: 16537793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring kainate receptor pharmacology using molecular dynamics simulations.
    Postila PA; Swanson GT; Pentikäinen OT
    Neuropharmacology; 2010 Feb; 58(2):515-27. PubMed ID: 19737573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kainate induces various domain closures in AMPA and kainate receptors.
    Venskutonytė R; Frydenvang K; Hald H; Rabassa AC; Gajhede M; Ahring PK; Kastrup JS
    Neurochem Int; 2012 Sep; 61(4):536-45. PubMed ID: 22425692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from crystal structures of kainate receptors.
    Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
    Neuropharmacology; 2017 Jan; 112(Pt A):16-28. PubMed ID: 27236079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding site and interlobe interactions of the ionotropic glutamate receptor GluK3 ligand binding domain revealed by high resolution crystal structure in complex with (S)-glutamate.
    Venskutonytė R; Frydenvang K; Gajhede M; Bunch L; Pickering DS; Kastrup JS
    J Struct Biol; 2011 Dec; 176(3):307-14. PubMed ID: 21907808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.
    Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS
    ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent pharmacological activity of novel marine-derived excitatory amino acids on glutamate receptors.
    Sanders JM; Ito K; Settimo L; Pentikäinen OT; Shoji M; Sasaki M; Johnson MS; Sakai R; Swanson GT
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1068-78. PubMed ID: 15914675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly and Trafficking of Homomeric and Heteromeric Kainate Receptors with Impaired Ligand Binding Sites.
    Scholefield CL; Atlason PT; Jane DE; Molnár E
    Neurochem Res; 2019 Mar; 44(3):585-599. PubMed ID: 30302614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
    Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
    Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and pharmacological characterization of phenylalanine-based AMPA receptor antagonists at kainate receptors.
    Venskutonytė R; Frydenvang K; Valadés EA; Szymańska E; Johansen TN; Kastrup JS; Pickering DS
    ChemMedChem; 2012 Oct; 7(10):1793-8. PubMed ID: 22407805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.
    Pallesen J; Møllerud S; Frydenvang K; Pickering DS; Bornholdt J; Nielsen B; Pasini D; Han L; Marconi L; Kastrup JS; Johansen TN
    ACS Chem Neurosci; 2019 Mar; 10(3):1841-1853. PubMed ID: 30620174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of MSVIII-19, a functional antagonist of the GluK1 kainate receptor.
    Qiu CS; Wyhe LL; Sasaki M; Sakai R; Swanson GT; Gereau RW
    Pain; 2011 May; 152(5):1052-1060. PubMed ID: 21324591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and structural characterization of conformationally restricted (S)-glutamate analogues at ionotropic glutamate receptors.
    Juknaitė L; Venskutonytė R; Assaf Z; Faure S; Gefflaut T; Aitken DJ; Nielsen B; Gajhede M; Kastrup JS; Bunch L; Frydenvang K; Pickering DS
    J Struct Biol; 2012 Oct; 180(1):39-46. PubMed ID: 22789682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.
    Fisher JL; Housley PR
    Cell Mol Neurobiol; 2013 Nov; 33(8):1099-108. PubMed ID: 23975096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding mode of an α-amino acid-linked quinoxaline-2,3-dione analogue at glutamate receptor subtype GluK1.
    Demmer CS; Møller C; Brown PM; Han L; Pickering DS; Nielsen B; Bowie D; Frydenvang K; Kastrup JS; Bunch L
    ACS Chem Neurosci; 2015 Jun; 6(6):845-54. PubMed ID: 25856736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.
    Fisher JL
    Neuropharmacology; 2015 Dec; 99():471-80. PubMed ID: 26277340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neto proteins regulate gating of the kainate-type glutamate receptor GluK2 through two binding sites.
    Li YJ; Duan GF; Sun JH; Wu D; Ye C; Zang YY; Chen GQ; Shi YY; Wang J; Zhang W; Shi YS
    J Biol Chem; 2019 Nov; 294(47):17889-17902. PubMed ID: 31628192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.